Health informatics and data collection company Medical Informatics announced its receipt of $27 million, made up of a $17 million Series B round plus $10 million in debt.
The equity round was co-led by Catalio Capital Management's venture capital strategy and Intel Capital, while Catalio Capital Management led the additional $10 million debt through its structured equity strategy.
New investors...
Real-world clinical data analytics company Verana Health scooped up $150 million in Series E funding.
The round was led by Johnson & Johnson Innovation and Novo Growth, with participation from GV, Casdin Capital, Brook Byers, Merck Global Health Innovation Fund, THVC and Breyer Capital. Verana plans to use the influx of capital to expand its life sciences products across the drug development...
LifeOmic, the maker of apps and other software for providers, has snagged former HHS CTO Ed Simcox as its new chief strategy officer. This role will task Simcox with development of the company’s health and security product strategies, as well as with the coordination of B2B partnerships and other relationships.
“Ed provides LifeOmic with invaluable experience helping change the way people...
This morning Verana Health, a startup focused on curating and analyzing real-world clinical data, announced a $100 million funding round led by GV with participation from Bain Capital Ventures, Casdin Capital and Define Ventures.
The funding news coincides with the announcement that Verana purchased PYA Analytics’ technology assets and team. PYA Analytics specializes in large-scale data...
Senior focused health tech startup K4Connect tapped Keith Stewart as the company’s next chief growth officer.
Stewart was formerly the chief revenue officer for smart building startup Site 1001. At K4Connect he will be responsible for expansion and growing sales.
“K4Connect is positioned perfectly to collaborate with our clients in order to help the industry usher in a next generation, senior-...
Tele-ophthalmology company DigiSight — now called Verana Health — has a new name, a new mission, a new CEO, and $30 million dollars in new funding led by Alphabet subsidiary GV (formerly Google Ventures). Additional contributors to the round include Biomatics Capital, Brook Byers (founder of Kleiner, Perkins, Caufield & Byers), GE Ventures, and Lagunita Biosciences, all existing investors.
"...
